FAQ/Help |
Calendar |
Search |
Today's Posts |
![]() |
|
ALS News & Research For postings of news or research links and articles related to ALS |
Reply |
|
Thread Tools | Display Modes |
|
![]() |
#1 | |||
|
||||
Grand Magnate
|
I am working on a review of this intervention, which received FDA approval in 2011
These threads involve introductory discussion of the principle of operation and were available 2001 . . . : Topic: Acetylcholine neurons - the ones that contact the mucle Acetylcholine neurons - the ones that contact the mucle - BrainTalk Communities - Neurology Support Groups Electrical device allows paralyzed man to breathe Electrical device allows paralyzed man to breathe - BrainTalk Communities - Neurology Support Groups |
|||
![]() |
![]() |
![]() |
#2 | |||
|
||||
Grand Magnate
|
DiPALS study survival medians were 28 months (pacer) , 45 months (NIV) . . . normal NIV survival is usually exceeds 36 months . . . thus, the question, 'Why were both results so poor?' remains open. RespiStimALS results were similar to the results used by the United States Food and Drug Administration to approve the treatment in Amyotrophic lateral Sclerosis.
Last edited by Chemar; 02-25-2021 at 07:05 PM. Reason: Edited by request of OP |
|||
![]() |
![]() |
![]() |
#3 | |||
|
||||
Grand Magnate
|
Non-invasive ventilation in amyotrophic lateral sclerosis
Non-invasive ventilation in amyotrophic lateral sclerosis In this report, several studies report NIV results of "Accordingly, more recent retrospective studies with larger numbers of patients (n = 929, n = 114, n = 140) found survival benefits of 13 months,4 11 months,5 and 15.5 months,6 respectively." Original finding place NIV at about 7 months. |
|||
![]() |
![]() |
Reply |
|
|
![]() |
||||
Thread | Forum | |||
Brief year in review, on the pacer . . . : (Happy New Year) | ALS News & Research | |||
Institut Guttmann trialing the pacer . . . : | ALS News & Research | |||
Happy New Year 2016 Pacer Graph | ALS News & Research | |||
Diaphragm pacer update | ALS |